Ganoderma
Ganoderma
Ganoderma, traditionally not associated with specific medicinal uses, is a fungal species that has been the subject of scientific research. Studies have shown that hypoxia can enhance the synthesis of ganoderic acid and inhibit biofilm development in Ganoderma lucidum, while also revealing the presence of two polysaccharides with antioxidant and immune-regulating properties. Additionally, findings indicate that FBG treatment may reduce lipid deposition and ROS levels, increase HDL-C, and boost antioxidant enzyme activities in liver cells. The scientific evidence is limited but suggests potential benefits for liver health and immune modulation. No significant safety concerns or drug interactions have been recorded to date.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- Hypoxia reduces cAMP levels, enhancing ganoderic acid synthesis while inhibiting biofilm development in Ganoderma lucidum.
- Two polysaccharides from Ganoderma lucidum cultivated under forest conditions were isolated and found to have antioxidant and immune-regulating properties.
- The study elucidated the membrane fouling mechanism of Ganoderma lucidum glycopeptides during nanofiltration and optimized ultrasonic-assisted parameters to improve separation efficiency.
- FBG treatment reduced lipid deposition and ROS levels while increasing HDL-C and antioxidant enzyme activities in liver cells.
- GLT intervention significantly attenuated colitis symptoms and modulated gut microbiota and metabolic profiles in DSS-induced mice.
- Structural differences in Ganoderma lucidum polysaccharide (GLP) led to distinct modulation of gut microbiota compared to other tested polysaccharides.
- The study developed an enzyme-assisted extraction method that increased the yield of Ganoderma lucidum polysaccharides by 6.96 times and showed immunomodulatory activity.
- Sporoderm disruption of Ganoderma lucidum spores increased extraction yield and modified polysaccharide characteristics, enhancing their mitochondrial protective activity without altering the backbone structure.
Frequently asked questions
What is Ganoderma?
Ganoderma (Ganoderma) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Ganoderma?
8 sourced findings are recorded for Ganoderma; the strongest carries evidence grade D. For example: Hypoxia reduces cAMP levels, enhancing ganoderic acid synthesis while inhibiting biofilm development in Ganoderma lucidum.
How strong is the evidence for Ganoderma?
The strongest finding for Ganoderma carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Ganoderma safe? What are the side effects?
No major safety issues are recorded for Ganoderma in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Ganoderma interact with medications?
No drug interactions are recorded for Ganoderma in our sources. This does not rule them out — check with a pharmacist.
What are the common names of Ganoderma?
Ganoderma is also known as: Ганодерма, Ganodermes.
Is Ganoderma a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 The Potential Alleviating Property Against NAFLD by Ganoderma lucidum With Bacteria-Enzyme Synergistic Fermentation. literature abstract metadata
- T2 Nanofiltration concentration process of Ganoderma lucidum glycopeptides and membrane fouling mechanism based on the ultrasonic-regulated adsorption and concentration kinetics. literature abstract metadata
- T2 Structural characterization and biological activity of polysaccharides from Ganoderma lucidum cultivated under forest conditions. literature abstract metadata
- T2 Hypoxia-induced downregulation of cAMP drives Ganoderic acid biosynthesis and restricts biofilm development in Ganoderma lucidum. literature abstract metadata
- T2 Sporoderm Disruption Reshapes the Chemical Characteristics and Enhances the Mitochondrial Protective Activity of Ganoderma lucidum Spore Polysaccharides via SIRT1/AMPK Signaling. literature abstract metadata
- T2 Comparative Insights into Digestion and Gut Microbiota Modulation of Polysaccharides from Ginseng, Ganoderma lucidum, and Dendrobium officinale. literature abstract metadata
- T2 Integrated Microbiome and Metabolomics Analysis Reveals That Ganoderma lucidum Triterpenoids Ameliorate Colitis Associated with the Modulation of the Gut Microbiota and Metabolic Profiles. literature abstract metadata
- T2 Enzyme-Assisted Extraction of Polysaccharides from Steam-Exploded Ganoderma lucidum and Its Yield, Structural Characterisation, and Immunomodulatory Activity. literature abstract metadata